Polymorphism of human cytochrome P450 enzymes and its clinical impact

SF Zhou, JP Liu, B Chowbay - Drug metabolism reviews, 2009 - Taylor & Francis
Pharmacogenetics is the study of how interindividual variations in the DNA sequence of
specific genes affect drug response. This article highlights current pharmacogenetic …

Role of interleukin-6 in the anemia of chronic disease

DSC Raj - Seminars in arthritis and rheumatism, 2009 - Elsevier
OBJECTIVES: To review evidence supporting the involvement of interleukin-6 in the
pathophysiology of anemia of chronic disease, to discuss the possible molecular …

Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects

LR Treviño, N Shimasaki, W Yang… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Methotrexate plasma concentration is related to its clinical effects. Our aim was to
identify the genetic basis of interindividual variability in methotrexate pharmacokinetics in …

Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic …

JD Lee, JE Huh, GS Jeon, HR Yang, HS Woo… - International …, 2009 - Elsevier
Rheumatoid arthritis (RA) is an aggressive inflammatory disease in which
cytokines/chemokines are thought to recruit leukocytes and induce angiogenesis. The aim of …

Therapeutic potential of splice-switching oligonucleotides

J Bauman, N Jearawiriyapaisarn, R Kole - Oligonucleotides, 2009 - liebertpub.com
Alternative splicing enables a single pre-messenger RNA transcript to yield multiple protein
isoforms, making it a major contributor to the diversity of the proteome. While this process is …

Epitope‐specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules …

EC Koffeman, M Genovese, D Amox… - … : Official Journal of …, 2009 - Wiley Online Library
Objective Induction of immune tolerance to maintain clinical control with a minimal drug
regimen is a current research focus in rheumatoid arthritis (RA). Accordingly, we are …

[HTML][HTML] Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds

X Deng, R Gujjar, F El Mazouni, W Kaminsky… - Journal of Biological …, 2009 - ASBMB
Malaria remains a major global health burden and current drug therapies are compromised
by resistance. Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) was …

Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity

G Falgarone, G Chiocchia - Advances in cancer research, 2009 - Elsevier
For years, clusterin has been recognized as a secreted protein and a large number of works
demonstrated that this ubiquitously expressed protein has multiple activities. Among the …

Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for …

MA Karsdal, K Henriksen, DJ Leeming, P Mitchell… - Biomarkers, 2009 - Taylor & Francis
The aim of this review is to discuss the potential usefulness of a novel class of biochemical
markers, neoepitopes, in the context of the US Food and Drug Administration (FDA) Critical …

[HTML][HTML] CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production

M Cutolo, S Soldano, P Montagna, A Sulli… - Arthritis research & …, 2009 - Springer
Introduction Co-stimulatory signal B7 (CD80/CD86): CD28 is needed in order to activate T
cells in immune response. Cytotoxic T lymphocyte-associated antigen-4-immunoglobulin …